Pagoclone | |
---|---|
Molecular structure via molpic based on CDK |
Physical properties [] | |
---|---|
Molecular mass | 407.9 g/mol [1] |
Predicted LogP | 4.6 [1] |
Structural Identifiers [] | |
---|---|
Molecular formula | C23H22ClN3O2 [1] |
IUPAC name | 2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxohexyl)-3H-isoindol-1-one [1] |
SMILES | CC(C)CCC(=O)CC1C2=CC=CC=C2C(=O)N1C3=NC4=C(C=C3)C=CC(=N4)Cl [1] |
InChI | InChI=1S/C23H22ClN3O2/c1-14(2)7-10-16(28)13-19-17-5-3-4-6-18(17)23(29)27(19)21-12-9-15-8-11-20(24)25-22(15)26-21/h3-6,8-9,11-12,14,19H,7,10,13H2,1-2H3 [1] |
InChIKey | HIUPRQPBWVEQJJ-UHFFFAOYSA-N [1] |
Pagoclone
Pagoclone (also known as IP 456, Pagoclona, IP-456, CI-1043, RP 62955, RP-62955, 2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxohexyl)-2,3-dihydro-1H-isoindol-1-one, 38VAG2SA33, pagoclonum or IP456) is a
Chemistry
Stereochemistry []
Pagoclone is a racemic mixture of the enantiomers
Stereoisomers |
---|
Anodyne Usernotes [] | |
---|---|
magnus / Pagoclone via Oral | - |
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 131664, Pagoclone. Accessed September 1, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/131664